EPCR protein: A key receptor for the activation and localization of the protein C anticoagulant system

Author: Senior Product Manager of UA Views：7

This article focuses on the molecular characteristics and anticoagulant functions of endothelial protein C receptor (EPCR), systematically elaborating its presentation role in the protein C activation process and its promoting mechanism for the recognition of protein C by the thrombin-thrombomodulin complex, analyzing the significance of high EPCR expression in the microcirculation for protein C activation and the localization of natural blood anticoagulation, and exploring the overall regulatory network of the protein C anticoagulant system and the core position of EPCR within it.

Recent Advances
Product Information

Recent Advances

EPCR Protein: A Key Receptor for Activation and Localization of the Protein C Anticoagulant System

Brief Introduction: This article focuses on the molecular characteristics and anticoagulant functions of endothelial protein C receptor (EPCR), systematically elaborating its presentation role in the protein C activation process and its promoting mechanism for the recognition of protein C by the thrombin-thrombomodulin complex. It analyzes the significance of high EPCR expression in the microcirculation for protein C activation and the localization of natural blood anticoagulation, and discusses the overall regulatory network of the protein C anticoagulant system and the central position of EPCR within it.

I. Amplification Characteristics of the Coagulation System and the Necessity of Anticoagulant Regulation.

Because the coagulation system can amplify the initiating stimulus, it will rapidly convert circulating blood into a thrombus if not effectively controlled. Therefore, the coagulation system is regulated by many anticoagulant mechanisms to ensure that the coagulation process is confined to the site of injury. Tissue factor pathway inhibitor is the first initiating control mechanism that regulates coagulation. Another control mechanism is the anticoagulant system regulated by protein C through two cofactors, FVIIIa and FVa. This dual regulatory system ensures that the coagulation response is fully activated locally at the site of injury while preventing the thrombus from spreading to the systemic circulation, and it is the core safeguard for maintaining the balance between blood fluidity and hemostatic function within blood vessels.

II. Composition and Activation Mechanism of the Protein C Anticoagulant System.

Protein C is a vitamin K-dependent protein activated by thrombin. Thrombin itself is a weak activator of protein C. Thrombomodulin is present on the surface of endothelial cells, and thrombin generated on intact endothelium binds to TM with high affinity. The binding of thrombin to TM results in the loss of the procoagulant activity of thrombin, and after activation by thrombin, protein C is converted to activated protein C. TM has the highest concentration in the microcirculation, which is very important for localizing protein C activation and the natural anticoagulation of blood. The half-life of APC produced in the circulation is 20 minutes. APC can be slowly inhibited by protein C inhibitor or α-1 antitrypsin. APC, together with its cofactor protein S, inhibits the coagulation pathway by specifically cleaving peptide bonds in FVIIIa and FVa, which are important cofactors of the coagulation pathway. Therefore, the core logic of the protein C anticoagulant system is that thrombin shifts from a procoagulant role to an anticoagulant activator, efficiently generating APC through the synergistic action of TM and EPCR, and then APC together with its cofactor protein S cleaves FVIIIa and FVa, thereby blocking the amplification step of the coagulation cascade.

III. The Presentation Role of EPCR in Protein C Activation.

Endothelial protein C receptor is also very important for the activation of protein C, and EPCR helps present protein C to the thrombin-TM complex. This presentation function is the core role of EPCR in the anticoagulant system——the concentration of protein C in plasma is limited, and EPCR significantly improves the efficiency of protein C activation by enriching protein C on the endothelial cell surface and presenting it to the thrombin-TM complex. The binding of EPCR to protein C has high affinity and specificity, and this binding enables protein C activation to proceed efficiently on the endothelial cell surface rather than relying on the inefficient process of random collisions in plasma. Therefore, EPCR is not only an auxiliary factor for protein C activation, but also a key molecule that determines the rate and spatial localization of the activation reaction.

IV. Synergistic Localization of EPCR and TM in the Microcirculation.

TM has the highest concentration in the microcirculation, which is very important for localizing protein C activation and the natural anticoagulation of blood. The co-localization of EPCR and TM on the endothelial cell surface concentrates protein C activation in the microcirculation, a key region prone to thrombosis and with slow blood flow. The microcirculation is the site where blood and tissues exchange substances and is also a common site of thrombus formation. Maintaining efficient anticoagulant activity in this region has important physiological significance for preventing microthrombus formation and protecting tissue perfusion. The role of EPCR in this spatial localization is reflected in its ability to “anchor” the activation reaction on the endothelial cell surface by presenting protein C, together with TM forming an efficient anticoagulant reaction platform. This synergistic localization mechanism ensures that anticoagulant activity is precisely activated at the site where it is needed, rather than being indiscriminately generated in the circulation.

V. Two Existing Forms of Protein S and the Complexity of Anticoagulant Regulation.

Protein S, like protein C, is also an important vitamin K-dependent protein. Another feature of protein S is that it exists in human plasma in two forms: free protein S, accounting for 30% to 40%, and bound protein S, which is a complex formed with complement C4b-binding protein. C4BP is composed of 7 identical α chains and 1 β chain; each α chain binds 1 complement C4b, and the β chain binds protein S, with the chain distribution resembling an octopus shape. Free protein S serves as an APC cofactor, while bound protein S binds to negatively charged membrane phospholipids through C4BP, which may be important for local control of complement system activation. The functional differentiation of the two forms of protein S reflects the complex cross-regulatory relationship between the anticoagulant system and the complement system, and also suggests a potential functional connection between the EPCR-mediated protein C activation pathway and the complement system.

VI. Conclusion.

In basic research related to EPCR and the exploration of anticoagulant mechanisms, high-quality recombinant EPCR protein is a core tool for dissecting its binding mechanism with protein C and evaluating anticoagulant regulatory activity. The His tag facilitates purification by immobilized metal affinity chromatography and enables detection and capture by anti-His tag antibodies. To meet the needs of EPCR functional research and exploration of the protein C anticoagulant system mechanism, U-protein provides EPCR/PROCR His Tag Protein, Human. This product is suitable for applications such as binding activity analysis of EPCR and protein C, research on the mechanism of EPCR-mediated protein C activation, analysis of the interaction between EPCR and the thrombin-TM complex, and the development of anticoagulant regulatory strategies.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Nanjing Univ is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UNIV Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next